NCT03631732 · Interventional trial
Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants
Overall registry status Completed
Phase 3
Conditions HIV-1 Infection
Delaware Valley sites
- Philadelphia FIGHT Community Health Centers · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory